全文获取类型
收费全文 | 8767篇 |
免费 | 1689篇 |
国内免费 | 614篇 |
专业分类
耳鼻咽喉 | 61篇 |
儿科学 | 88篇 |
妇产科学 | 164篇 |
基础医学 | 718篇 |
口腔科学 | 78篇 |
临床医学 | 1157篇 |
内科学 | 678篇 |
皮肤病学 | 129篇 |
神经病学 | 308篇 |
特种医学 | 317篇 |
外科学 | 893篇 |
综合类 | 1888篇 |
现状与发展 | 3篇 |
预防医学 | 2215篇 |
眼科学 | 213篇 |
药学 | 1280篇 |
22篇 | |
中国医学 | 517篇 |
肿瘤学 | 341篇 |
出版年
2024年 | 67篇 |
2023年 | 336篇 |
2022年 | 724篇 |
2021年 | 868篇 |
2020年 | 651篇 |
2019年 | 427篇 |
2018年 | 449篇 |
2017年 | 324篇 |
2016年 | 384篇 |
2015年 | 411篇 |
2014年 | 933篇 |
2013年 | 929篇 |
2012年 | 1223篇 |
2011年 | 1316篇 |
2010年 | 880篇 |
2009年 | 556篇 |
2008年 | 111篇 |
2007年 | 30篇 |
2006年 | 29篇 |
2005年 | 14篇 |
2004年 | 14篇 |
2003年 | 24篇 |
2002年 | 32篇 |
2001年 | 35篇 |
2000年 | 58篇 |
1999年 | 22篇 |
1998年 | 29篇 |
1997年 | 30篇 |
1996年 | 21篇 |
1995年 | 26篇 |
1994年 | 13篇 |
1993年 | 12篇 |
1992年 | 15篇 |
1991年 | 10篇 |
1990年 | 5篇 |
1989年 | 8篇 |
1988年 | 14篇 |
1987年 | 12篇 |
1986年 | 15篇 |
1985年 | 1篇 |
1984年 | 10篇 |
1983年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
81.
82.
83.
Zirui Lü Xiaona Li Kebin Li Cong Wang Tingting Du Wei Huang Ming Ji Changhong Li Fengrong Xu Ping Xu Yan Niu 《ACS medicinal chemistry letters》2021,12(5):696
We identified nitazoxanide (NTZ) as a moderate STAT3 pathway inhibitor through immunoblot analysis and a cell-based IL-6/JAK/STAT3 pathway activation assay. A series of thiazolide derivatives were designed and synthesized to further validate the thiazolide scaffold as STAT3 inhibitors. Eight out of 25 derivatives displayed potencies greater than that of NTZ, and their STAT3 pathway inhibitory activities were found to be significantly correlated with their antiproliferative activities in HeLa cells. Derivatives 15 and 24 were observed to be more potent than the positive control WP1066, which is under phase I clinical trials. Compared with NTZ, 15 also exhibited much improved in vivo pharmacokinetic parameters in rats and efficacies against proliferations in multiple cancer cell lines, indicating a broad-spectrum effect of these thiazolides as antitumor agents targeted on STAT3. 相似文献
84.
85.
ObjectivesTo explore the effects of acupuncture (manual acupuncture or electroacupuncture) combined with SSRIs for moderate to severe depression improving major clinical symptoms and life quality of the patients on secondary outcomes.DesignPragmatic, parallel, randomized controlled trial.Setting6 hospitals in China.Interventions6 weeks of manual acupuncture (MA)+selective serotonin reuptake inhibitors (SSRIs), electroacupuncture (EA)+SSRIs, and SSRIs alone.Main outcome measuresThe primary outcome was response rate of 17-item Hamilton Depression Scale (HAMD-17) total score at 6th week. The secondary outcomes reported in this analysis were HAMD-17 factor scores at 1st, 2nd, 4th, 6th, 10th week and WHO Quality of Life-BREF (WHOQOL-BREF) scores at 6th week.Results477 patients were randomly assigned into MA + SSRIs (n = 161), EA + SSRIs (n = 160), or SSRIs alone (n = 156) groups. For HAMD-17 (at 6th week), the MA + SSRIs group was significantly better than the SSRIs alone group in retardation factor (p = 0.008), while the EA+SSRIs group was significantly better than the SSRIs alone group in anxiety/somatization factor (p<0.001) and sleep disturbance factor (p = 0.002). For WHOQOL-BREF (at 6th week), the EA + SSRIs group, compared with the SSRIs alone group, produced a more significant improvement in the overall quality of life, general health, physical health, and psychological health (p<0.05). While, the MA + SSRIs group, compared to the SSRIs alone group, showed significant advantage only in psychological health (p = 0.023).ConclusionsEither MA or EA combined SSRIs treatment could improve symptoms and quality of life for patients with moderate to severe depression. The main limitation of this trial was not using a sham control therefore the placebo effect could not be excluded. 相似文献
86.
《Health & place》2021
During the past decades, China has experienced rapid urbanization and aging. This study investigated sex-stratified urban-rural disparities in age trajectories of physiological health in China. We obtained data from 21686 individuals aged 45 years or above from 2011 baseline survey of the China Health and Retirement Longitudinal Study (CHARLS) and the 2015 follow-up. It examined 11 biomarkers of physiological health classified into four summary indices: cardiovascular index, metabolic index, inflammation index, and allostatic load. This study found that the “urban health penalty” approach dominates the “urban health advantage” approach in middle and early old age, but the dominance of the “urban health penalty” approach is offset or even reversed by the “urban health advantage” approach in older age. 相似文献
87.
《American journal of otolaryngology》2023,44(2):103692
BackgroundDysthyroid optic neuropathy (DON) is a serious complication of thyroid-associated ophthalmopathy (TAO) that can cause permanent vision loss from orbital apex syndrome. Urgent management of high-dose corticosteroid pulse therapy is recommended, and salvage orbital apex decompression surgery may require in refractory patients ineffective with corticosteroid pulse therapy.PurposeTo evaluate the short-term efficacy and safety of combined endoscopic endonasal and orbital approach decompression in the annulus of the Zinn (AZ) area in refractory dysthyroid optic neuropathy (DON).MethodsIn this retrospective study, patients who underwent combined endoscopic endonasal and orbital approach decompression around the AZ area for the treatment of refractory DON from May 2021 to March 2022 were enrolled. A total of 15 orbital apex were decompressed across 9 patients. The demographic, imaging, and surgical data, as well as preoperative and postoperative best corrected visual acuity (BCVA), proptosis degree and Modified-Chinese-TAO-QOL scores, were collected and assessed. The t-test was used to identify differences between preoperative and postoperative parameters: visual acuity, proptosis and QOL scores.ResultsThe mean best corrected visual acuity (BCVA) improved from 0.79 ± 0.77 LogMAR preoperatively to 0.21 ± 0.27 LogMAR (P < 0.001) postoperatively. Additionally, proptosis decreased from 22.25 ± 2.01 mm to 18.42 ± 1.85 mm (P < 0.01), with an average decrease of 3.7 mm. The preoperative scores of the visual, psychological, and comprehensive components of QoL were 14.60 ± 9.08, 37.49 ± 6.26 and 26.75 ± 3.70, respectively, which significantly improved postoperatively to 54.18 ± 7.23, 68.78 ± 12.53 and 61.88 ± 9.37, respectively. The postoperative follow-up time ranged from 2 to 11 months, and the median follow-up time was 7 months. There was 1 case of transient postoperative sinusitis and 1 new case of transient diplopia, which was relieved after 3 months.ConclusionCombined endoscopic endonasal and orbital approach adequate decompression for AZ area significantly improves visual acuity and QOL in patients with DON. 相似文献
88.
89.
90.